Accepted for/Published in: JMIR Research Protocols
Date Submitted: Aug 14, 2026
Date Accepted: Oct 30, 2026
A Comprehensive Intervention to Enhance Treatment Engagement and Retention Following Non-Fatal Opioid Overdose: Protocol for a Feasibility Study
ABSTRACT
Background:
Substance use treatment engagement and retention after hospital discharge remains low among patients with nonfatal opioid overdose. It is critical to develop interventions targeting this population due to persistent opioid overdose crisis. We conducted a prospective study using a bundled intervention to engage patients, increase treatment uptake and retention, and reduce repeat overdoses.
Objective:
The objective of this study was to evaluate the feasibility and acceptability of a 12-week, bundled, telehealth-enabled intervention designed to improve treatment engagement and retention among hospitalized patients with opioid use disorder and a recent nonfatal opioid overdose.
Methods:
This 12-week comprehensive intervention comprises four components, including buprenorphine treatment, telehealth physician visits (weeks 1, 3, 5, 9, and 12, and as needed), telehealth peer service (daily during week 1, every other day during week 2, weekly during weeks 3–12), and facilitated linkage to community resources and ongoing treatment. Adults aged 19 years or older with a diagnosis of opioid use disorder (OUD) and a nonfatal opioid overdose within the last 12 months were recruited before they were discharged from the University of Alabama at Birmingham Hospital. After enrollment, buprenorphine treatment was initiated or continued, and peer support specialists began engaging and coaching patients. Upon discharge, patients received continuous care via telehealth from both physicians and peers for up to 12 weeks. Participants completed validated surveys at baseline, 1 month, and 3 months.
Results:
This study is the first phase of a two-phase research project funded by National Institute on Drug Abuse. By April 2026, 30 participants enrolled and completed the intervention to test the feasibility and acceptability. Preliminary results yielded from the first phase will be published in the winter of 2026.
Conclusions:
Our findings suggest that this bundled, telehealth-enabled intervention is feasible and acceptable, and may increase treatment uptake and retention in patients at high risk for repeat overdose and death. This intervention will be further evaluated in an ongoing randomized controlled trial, which aims to demonstrate effectiveness in an estimated sample of 160 patients in the second phase of the project. Clinical Trial: NCT: 06593093
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.